Literature DB >> 25616359

[Demography and age-dependency in ophthalmic diseases].

C Wolfram1.   

Abstract

This article explains key terms in demography and describes current and future changes in the composition of the German population. The ratio of older persons is greatly increasing as age groups from higher birth rates are growing older and as the life expectancy continues to rise particularly for older age groups. Ophthalmology is highly affected by these societal changes as eye diseases particularly affect the elderly. The prevalence of blindness and low vision is increasing in the older population even though this increase is being overlapped by a general reduction in the risk of blindness. Up to more than 30% more age-related eye diseases are expected in the population by the year 2030, which will lead to an additional roughly 7.7 million ophthalmic consultations in the population of more than 60 years of age. The healthcare units need to be adjusted to the rising demand for ophthalmic care.

Entities:  

Mesh:

Year:  2015        PMID: 25616359     DOI: 10.1007/s00347-014-3182-1

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN: 0941-293X            Impact factor:   1.059


  8 in total

1.  Prevalence of open-angle glaucoma among adults in the United States.

Authors:  David S Friedman; Roger C W Wolfs; Benita J O'Colmain; Barbara E Klein; Hugh R Taylor; Shelia West; M Cristina Leske; Paul Mitchell; Nathan Congdon; John Kempen
Journal:  Arch Ophthalmol       Date:  2004-04

2.  Regional differences in the prevalence of known Type 2 diabetes mellitus in 45-74 years old individuals: results from six population-based studies in Germany (DIAB-CORE Consortium).

Authors:  S Schipf; A Werner; T Tamayo; R Holle; M Schunk; W Maier; C Meisinger; B Thorand; K Berger; G Mueller; S Moebus; B Bokhof; A Kluttig; K H Greiser; H Neuhauser; U Ellert; A Icks; W Rathmann; H Völzke
Journal:  Diabet Med       Date:  2012-07       Impact factor: 4.359

3.  The prevalence of age-related macular degeneration and associated risk factors.

Authors:  Ronald Klein; Karen J Cruickshanks; Scott D Nash; Elizabeth M Krantz; F Javier Nieto; Guan H Huang; James S Pankow; Barbara E K Klein
Journal:  Arch Ophthalmol       Date:  2010-06

4.  Prevalence of age-related maculopathy in older Europeans: the European Eye Study (EUREYE).

Authors:  Cristina A Augood; Johannes R Vingerling; Paulus T V M de Jong; Usha Chakravarthy; Johan Seland; Gisele Soubrane; Laura Tomazzoli; Fotis Topouzis; Graham Bentham; Mati Rahu; Jesus Vioque; Ian S Young; Astrid E Fletcher
Journal:  Arch Ophthalmol       Date:  2006-04

5.  Prevalence of cataract and pseudophakia/aphakia among adults in the United States.

Authors:  Nathan Congdon; Johannes R Vingerling; Barbara E K Klein; Sheila West; David S Friedman; John Kempen; Benita O'Colmain; Suh-Yuh Wu; Hugh R Taylor
Journal:  Arch Ophthalmol       Date:  2004-04

6.  [Utilization of outpatient and inpatient health services in Germany: results of the German Health Interview and Examination Survey for Adults (DEGS1)].

Authors:  P Rattay; H Butschalowsky; A Rommel; F Prütz; S Jordan; E Nowossadeck; O Domanska; P Kamtsiuris
Journal:  Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz       Date:  2013-05       Impact factor: 1.513

7.  Prevalence of open-angle glaucoma in Greece: the Thessaloniki Eye Study.

Authors:  Fotis Topouzis; M Roy Wilson; Alon Harris; Eleftherios Anastasopoulos; Fei Yu; Leonidas Mavroudis; Theofanis Pappas; Archimidis Koskosas; Anne L Coleman
Journal:  Am J Ophthalmol       Date:  2007-10       Impact factor: 5.258

8.  The Beaver Dam Eye Study. Retinopathy in adults with newly discovered and previously diagnosed diabetes mellitus.

Authors:  R Klein; B E Klein; S E Moss; K L Linton
Journal:  Ophthalmology       Date:  1992-01       Impact factor: 12.079

  8 in total
  1 in total

1.  [Epidemiology of severe visual impairment and blindness of old people in Germany].

Authors:  M M Mauschitz; J Q Li; P P Larsen; J Köberlein-Neu; F G Holz; M M B Breteler; R P Finger
Journal:  Ophthalmologe       Date:  2019-02       Impact factor: 1.059

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.